Trials / Completed
CompletedNCT01303627
Safety of Remifentanil Infusion
The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Diskapi Teaching and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.
Detailed description
In all patients (control group and remifentanil group induction of anesthesia will be achieved with desflurane and remifentanil.Anesthesia will be maintained with remifentanil (1-4 ng/mL) by TCI target controlled infusion, and desflurane . Throughout the surgery hemodynamic parameters are going to be recorded. As soon as the surgery has been finished, in control group remifentanil infusion and desflurane inhalation is going to be stopped.In remifentanil group,desflurane inhalation is going to be stopped and remifentanil infusion will be maintained until the removal of LMA. During the emergence period the time of eye opening, hemodynamic parameters and emergence quality (score 1-2)are going to be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remifentanil | 1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-03-01
- Completion
- 2011-04-01
- First posted
- 2011-02-25
- Last updated
- 2012-06-25
- Results posted
- 2012-06-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01303627. Inclusion in this directory is not an endorsement.